Towa Pharmaceutical (TWAPF) Stock Price, News & Analysis

Company Overview

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners. Its facilities are equipped for small- to medium-scale production of high-purity APIs, intermediates and specialized dosage forms. The company also maintains research collaborations with academic institutions and contract research organizations, focusing on formulation optimization, process improvement and regulatory compliance.

Headquartered in Japan, Towa Pharmaceutical distributes its products across Asia and exports to markets in Europe and North America. The company’s global footprint is supported by a network of sales agents and regulatory specialists who ensure adherence to regional quality standards and approval processes. While Towa Pharmaceutical has steadily expanded its international presence in recent years, it continues to emphasize innovation in pharmaceutical technology and supply chain reliability.

Key Stats

• Today's Range: $25.98 to $25.98
• 50-Day Range: $25.33 to $26.00
• 52-Week Range: $25.71 to $26.00
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Company Calendar

• Today: 9/10/2026
• Next Earnings (Estimated): 11/16/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:TWAPF
• CIK: N/A
• Web: www.towayakuhin.co.jp
• Phone: 81669009100
• Fax: N/A
• Employees: 4,588
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A